| Acute Leukemia |
1 |
0.91 |
| Stem Cell Research and Therapy |
0 |
0.64 |
| Child |
0 |
0.6 |
| Refractory |
0 |
0.6 |
| Acute Myeloblastic Leukemia |
0 |
0.59 |
| Biologic Therapy |
0 |
0.58 |
| Transplantation |
0 |
0.44 |
| Toxicology |
0 |
0.39 |
| Young Adult |
0 |
0.22 |
| Pediatric Transplantation |
0 |
0.19 |
| CAR-T |
0 |
0.16 |
| Palliative Care |
0 |
0.12 |
| Leukemia |
0 |
0.11 |
| Bridge to Transplantation |
0 |
0.08 |
| Adolescent Medicine |
0 |
0.06 |
| Antigens |
0 |
0.06 |
| Blood |
0 |
0.06 |
| California |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Chemotherapy |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Geriatrics |
0 |
0.06 |
| Hematology |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Remission |
0 |
0.06 |
| Residual Disease |
0 |
0.06 |
| T-Lymphocyte |
0 |
0.06 |